Study points to barriers to biologic treatments for some patients with psoriasis

In the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts have found that black patients receiving Medicare are less likely to receive biologic therapies -medications derived from human or animal cells or tissues -- for the treatment of moderate to severe psoriasis than white patients.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1NMxxDn